Ischemic central retinal vein occlusion (CRVO) remains one of the leading causes of blindness among retinal vascular disorders, second only to diabetic retinopathy in causes of visual loss [1]. There is a significant prevalence of this disorder in the elderly population, with an incidence of 1.3% in the aged 65 and older [2,3]. The fundus of a patient with ischemic CRVO gives an appearance of e...

AIM We aimed to evaluate the 1-year efficacy and safety of low-frequency intravitreal bevacizumab in the treatment of macular edema due to retinal vein occlusions (RVOs). METHODS The study comprised an interventional prospective study of patients with macular edema due to central retinal vein occlusion (CRVO) or branch retinal vein occlusion, followed for 12 months. Treatment-naïve patients w...

Central retinal vein occlusion (CRVO) with capillary non-perfusion predisposes to retinal neovascularisation and rubeosis iridis (Laatikainen and Kohner, 1976). Studies on diabetic retinopathy suggest that destroying large areas of hypoxic retina or reducing its metabolic demands prevents neovascularisation and may cause retinal vessels to regress (Taylor, 1970). It was therefore decided to try...

Systemic lupus erythematosus (SLE) is a chronic, multisystem, autoimmune disease that can affect any part of the human body including the eyes. Common blinding ocular manifestations include central retinal artery occlusion (CRAO), central retinal vein occlusion (CRVO), severe vaso-occlusive retinopathy, and optic nerve involvement. Antiphospholipid syndrome (APS) in lupus is usually associated ...

The authors report a rare case of a 47-year-old woman with Crohn's disease (CD) who presented with retinal vasculitis and central retinal vein occlusion (CRVO) during remission. The patient complained of sudden painless visual loss in her left eye (OS). Ophthalmologic evaluation revealed a best corrected visual acuity (BCVA) of 20/20 in the right eye and hand movements in OS. Ophthalmoscopy and...

This report describes a case of angiographically documented foveal avascular zone (FAZ) enlargement after a single intravitreal injection of bevacizumab for macular edema secondary to central retinal vein occlusion (CRVO). A 71-year-old female was treated with an intravitreal bevacizumab injection for macular edema following CRVO. Despite successfully decreased edema one month after injection, ...

We studied the seasonal incidence of onset of symptoms of central retinal vein occlusion (CRVO) in 105 patients over a 5-year period. Their onset showed a significant cyclic variation (p less than 0.01), being most frequent in the months September through to February. We believe this seasonal variation may in part reflect seasonal changes in haemostasis and retinal perfusion, though other unide...

A case of retinal central vein occlusion (CRVO) in a 43-year-old man is presented in which hyperbaric oxygen (HBO2) was used as the only treatment method. CRVO is a relatively common cause of visual loss, with hypertension, diabetes, glaucoma and hypercoagulable conditions identified as risk factors. The patient in this report had none of these risk factors and declined treatments other than hy...

Here, we report a case with cystoid macular edema (CME) due to central retinal vein occlusion (CRVO) presented with a dexamethasone implant (Ozurdex) trapped at the macula in her silicone oil- (SO-) filled eye after injection. No additional complications such as intraocular pressure (IOP) rise or retinal damage were observed. The CME was resolved during the follow-up period. At the last visit, ...

Central retinal vein occlusion (CRVO) can cause vision loss. The pathogenesis of CRVO involves a thrombus formation leading to increased retinal capillary pressure, increased vascular permeability, and possibly retinal neovascularization. Vision loss due to CRVO is commonly caused by macular edema. Multiple treatment modalities have been used to treat macular edema. Currently, the most common t...